România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rocuronium kabi 10 mg/ml
fresenius kabi austria gmbh - austria - bromurĂ de rocuronium - sol. inj./perf. - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
rocuronium aguettant 10 mg/ml
laboratoire aguettant - franta - bromurĂ de rocuronium - sol inj. in seringa preumpluta - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
esmeron 10 mg/ml
n.v. organon - olanda - bromurĂ de rocuronium - sol. inj. - 10mg/ml - miorelaxante periferice derivati cuaternari de amoniu
Uniunea Europeană -
română -
EMA (European Medicines Agency)
bridion
merck sharp & dohme b.v. - sugammadex - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. pentru populația pediatrică: sugammadex este recomandat numai pentru reversia de rutină de rocuronium-a indus blocada la copii și adolescenți.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - blocaj blocant - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sugammadex medichem 100 mg/ml
medichem s.a. - spania - sugammadexum - sol. inj. - 100mg/ml - alte preparate terapeutice preparate antidot